Jonathan I. Silverberg, MD, PhD, MPH

Director of Clinical Research
George Washington University

Poster(s):

• (101) Improvement in atopic dermatitis signs and symptoms with once-daily and proactive twice-weekly roflumilast cream 0.15% or 0.05%: results from the 52-week phase 3 INTEGUMENT-OLE trial in patients aged ≥2 years
  Wednesday, October 29, 2025